loader

Pharmala Biotech Holdings Inc.

CNSX:MDMA
MDXXF
Featured Articles and Interviews

US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025

Press Releases

Pharmala Biotech Holdings Inc is focused on manufacturing and sales of MDMA and MDXX Active Pharmaceutical Ingredients (API) for use in clinical research. PharmAla's drug API is manufactured and encapsulated under GMP conditions.

Interactive Chart

×